SCHEMBL20042700

SCHEMBL20042700

COc1c(Cl)cc(C(=O)N2Cc3nc(C)nc(N4CCC4)c3C2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
P2RX7 Q99572 4/20 0.36
LMNA P02545 4/20 0.36
NR4A1 P22736 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
ACLY P53396 2/20 0.35
LRRK2 Q5S007 2/20 0.35
HSP90AA1 P07900 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042680 0.87 GPR6 (0.44) TSHRKDM4EHPGDCASP1CASP7
SCHEMBL20042689 0.86 P2RX7 (0.39) CASP1CASP7HSD17B10P2RX7SMN1; SMN2
SCHEMBL20042886 0.85 HPGD (0.49) TSHRHPGDP2RX7KMT2AHSD11B1
SCHEMBL20042752 0.85 HPGD (0.47) TSHRHPGDP2RX7LMNASMN1; SMN2
SCHEMBL20042743 0.83 P2RX7 (0.40) TSHRKDM4EHPGDCASP1CASP7
SCHEMBL20042720 0.83 GRM5 (0.41) P2RX7HSP90AA1
SCHEMBL20042854 0.83 GRM5 (0.42) TSHRKDM4EHPGDCASP1CASP7
SCHEMBL20042667 0.82 TACR3 (0.46) P2RX7
SCHEMBL20042887 0.82 GPR6 (0.42) TSHRHPGDP2RX7SMN1; SMN2ALDH1A1
SCHEMBL20042751 0.81 HSD17B10 (0.49) KDM4EHPGDCASP1CASP7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed